Bios Wins the “Global Hemoglobin Oxygen Carrier Technology Innovation Leadership Award” at the Sullivan New Investment Conference 2025
2025-08-29
On August 27, the 19th Sullivan Global Growth, Technology Innovation and Leadership Summit 2025 and the 4th New Investment Conference (hereinafter referred to as “Sullivan New Investment Conference 2025”) was grandly opened in Shangri-La Hotel, Jing ’an District, Shanghai.
On the occasion of the conference, the Sullivan Global Growth, Technology Innovation and Leadership Awards 2025 annual Award Ceremony and VIP Appreciation Dinner were held, and the Sullivan Global Award, China Award and Best Practice Award were announced.
Bios received the “Global Hemoglobin Oxygen Carrier Technology Innovation Leadership Award” at the 2025 Sullivan New Investment Conference. Hazmi Yusof, Senior Vice President and Head of Sullivan Malaysia, and Professor Wang Yu, Chairman of China Hepatitis Prevention and Control Foundation, expert advisor of Sullivan Global Expert Advisory Panel, and winner of Sullivan Special Contribution Award for Greater China 2024, presented the award to Bios Biotech.
Bios Biotechnology Co., LTD. (BIOS) was founded in 2024, headquartered in Hong Kong, China, focusing on the development and industrial production of biomedicine and medical device products based on hemoglobin oxygen carriers. Through intravenous injection, extracorporeal circulation and other ways, the company’s products can effectively provide oxygen for the whole body and various tissues and organs. Up to now, BIOS has become a global leader in the development of hemoglobin for human and veterinary use.
-
Bios Wins the “Global Hemoglobin Oxygen Carrier Technology Innovation Leadership Award” at the Sullivan New Investment Conference 2025
On August 27, the 19th Sullivan Global Growth, Technology Innovation and Leadership Summit 2025 and the 4th New Investment Conference (hereinafter referred to as “Sullivan New Investment Conference 2025”) was grandly opened in Shangri-La Hotel, Jing ’an District, Shanghai.
2025-08-29
-
Wang Jianfeng, the Secretary of the CPC Changzhou Municipal Committee, met with Mr. Zheng Zhiheng, the Chairman of Bios Biologics
On 28 May 2025, Wang Jianfeng, Party Secretary of Changzhou City, Jiangsu Province, met with Mr. Zheng Zhiheng, Chairman of Bios Biotechnology Co., LTD., Vice Chairman and Executive Director of Chow Tai Fok Jewelry Group Co., LTD., to exchange views on further deepening cooperation.
2025-05-29
-
Yale scientists have successfully revived a pig brain with artificial blood
Recently, the cover of Nature published the latest research from Yale University School of Medicine: scientists at Yale University used an infusion solution to successfully revive the pig brain after 4 hours of death, restoring some cellular and metabolic functions, and maintaining them for at least 6 hours.
2024-08-03
-
A brief history of research and development of red blood cell substitutes
Blood has always been a very important, but very limited medical resource.
2024-08-02
